Detalles de la búsqueda
1.
Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic.
Proc Natl Acad Sci U S A
; 119(40): e2210941119, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126098
2.
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments.
Value Health
; 23(5): 616-624, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389227
3.
Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
BMC Cardiovasc Disord
; 20(1): 418, 2020 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32942999
4.
Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Ann Intern Med
; 170(1): 1-10, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30508425
5.
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Am Heart J
; 210: 18-28, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30716508
6.
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling.
Health Qual Life Outcomes
; 17(1): 186, 2019 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31856842
7.
Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.
BMC Cardiovasc Disord
; 18(1): 97, 2018 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29776337
8.
Large-scale prevention trials could provide stronger evidence for decision-makers: Opportunities to design and report with a focus on the benefit-harm balance.
Clin Trials
; 19(2): 224-226, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35152791
9.
Rejoinder to Dr Vickers.
Clin Trials
; 19(2): 229-230, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35152804
10.
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
Antimicrob Agents Chemother
; 60(10): 6134-45, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27480867
11.
Statins for Primary Prevention of Cardiovascular Disease.
Ann Intern Med
; 171(1): 74-76, 2019 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31261399
12.
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results.
PLoS One
; 18(3): e0282658, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36867630
13.
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.
BMJ
; 381: e074425, 2023 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37257891
14.
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.
medRxiv
; 2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37745521
15.
Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US.
JAMA Neurol
; 80(9): 919-928, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459088
16.
Fingolimod versus interferon beta 1-a: Benefit-harm assessment approach based on TRANSFORMS individual patient data.
Mult Scler J Exp Transl Clin
; 8(3): 20552173221117784, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36092642
17.
Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study.
JMIR Public Health Surveill
; 8(5): e35653, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476726
18.
Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations-A population-based cohort study.
PLoS One
; 17(3): e0264655, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294465
19.
COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data.
Lancet Public Health
; 7(9): e744-e753, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057273
20.
Excess natural-cause deaths in California by cause and setting: March 2020 through February 2021.
PNAS Nexus
; 1(3): pgac079, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35832865